Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	View
JYSB2500152	仑卡奈单抗注射液	lecanemab	Injection	Biological Products(1)	Supplementary Application	2025-06-27	Biogen US Corp;Eisai Inc	view
JYSB2500153	仑卡奈单抗注射液	lecanemab	Injection	Biological Products(1)	Supplementary Application	2025-06-27	Biogen US Corp;Eisai Inc	view
JXSL2500046	仑卡奈单抗注射液（皮下注射）	lecanemab	Injection	Biological Products(2.1)	Import Drug Application	2025-03-27	Eisai Co Ltd;Eisai China Inc	view
JXSB2300090	仑卡奈单抗注射液	lecanemab	Injection	Biological Products(1)	Supplementary Application	2023-07-13	Eisai Co Ltd;Biogen US Corp	view
JXSS2200040	仑卡奈单抗注射液	lecanemab	Injection	Biological Products(1)	Import Drug Application	2022-12-22	Eisai China Inc;Biogen US Corp;Eisai Inc	view
JXSS2200039	仑卡奈单抗注射液	lecanemab	Injection	Biological Products(1)	Import Drug Application	2022-12-22	Eisai China Inc;Biogen US Corp;Eisai Inc	view